Printer Friendly
The Free Library
19,607,059 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Critical Therapeutics to Announce Second Quarter 2005 Financial Results on August 4, 2005.


LEXINGTON, Mass. -- Critical Therapeutics therapeutics

Treatment and care to combat disease or alleviate pain or injury. Its tools include drugs, surgery, radiation therapy, mechanical devices, diet, and psychiatry.
, Inc. (NASDAQ NASDAQ
 in full National Association of Securities Dealers Automated Quotations

U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on
: CRTX), a biopharmaceutical company engaged in the discovery, development and commercialization of products for respiratory, inflammatory and critical care diseases, will conduct a conference call at 5:00 p.m. ET Thursday, August 4, 2005, following the release of its second quarter 2005 financial results. Critical Therapeutics President and Chief Executive Officer Paul Rubin, M.D. will lead the call, during which senior management will discuss the Company's second quarter financial results, recent accomplishments and upcoming milestones.

Investors and others are invited to listen live via telephone or the Internet.
What: Critical Therapeutics Second Quarter 2005 Financial Results
    Conference Call

When: 5:00 p.m. ET Thursday, August 4, 2005

Dial-in: From the U.S. and Canada, dial (800) 289-0730
         International callers, dial (913) 981-5509

Confirmation Code: 6524239

Webcast: Visit www.crtx.com, go to the "Investors" page and then click
    on the conference call link about five minutes before the call.


To access the replay, visit www.crtx.com, click on "Investors" and then on "Webcasts & Presentations."

About Critical Therapeutics, Inc.

Critical Therapeutics, Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of products for respiratory, inflammatory and critical care diseases. The Company is developing a sales and marketing infrastructure in connection with its in-licensed product, ZYFLO(R), a tablet See digitizer tablet and tablet computer.

TABLET - A query language.

["Human Factor Comparison of a Procedural and a Non-procedural Query Language", C. Welty et al, ACM Trans Database Sys 6(4):626-649 (Dec 1981)].
 formulation formulation /for·mu·la·tion/ (for?mu-la´shun) the act or product of formulating.

American Law Institute Formulation
 of zileuton zileuton /zi·leu·ton/ (zi-loo´ton) an inhibitor of leukotriene formation, used as an antiasthmatic.
Zileuton (Zyflo) 
. Critical Therapeutics also is developing treatments directed toward the severe inflammatory response in acute diseases and conditions that lead to admission to the emergency room or intensive care unit, and acute exacerbations of other chronic diseases that frequently lead to hospitalization hospitalization /hos·pi·tal·iza·tion/ (hos?pi-t'l-i-za´shun)
1. the placing of a patient in a hospital for treatment.

2. the term of confinement in a hospital.
. For more information, please visit www.crtx.com
COPYRIGHT 2005 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2005, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:1USA
Date:Jul 28, 2005
Words:272
Previous Article:Rogue Wave Software Releases Sourcepro C++ Edition 8.
Next Article:Research and Markets: Presenting the Hungarian Office Products Market 2004-09 in English.
Topics:



Related Articles
Critical Therapeutics, Inc. to Announce Second Quarter Financial Results on August 4, 2004.
Critical Therapeutics to Announce First Quarter 2005 Financial Results on May 10, 2005.
Critical Therapeutics Reports First Quarter 2005 Financial Results.
Critical Therapeutics Reports Second Quarter 2005 Financial Results.
Critical Therapeutics Reports Fourth Quarter and Full Year 2005 Financial Results; Reports initial data from launch of ZYFLO(R) (zileuton tablets).
Critical Therapeutics Reports First Quarter 2006 Financial Results and Announces Reductions to Operating Expense Guidance.
Critical Therapeutics to Announce Second-Quarter 2006 Financial Results on August 3.
Critical Therapeutics Reports Second Quarter 2006 Financial Results.
Critical Therapeutics Reports Third Quarter 2006 Financial Results.
Critical Therapeutics Reports Financial Results for the Quarter and Year Ended December 31, 2006.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles